• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
CRSP

CRSP

CRISPR Therapeutics AG

NASDAQHealthcareBiotechnologyCH

USD52.08

+0.06 (+0.12%)

Rating:C-

Company Profile

CEO

Samarth Kulkarni

IPO Date

2016-10-19

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

CH

Market Metrics

Open

$51.29

Prev. Close

$52.02

Day Low

$50.52

Day High

$52.28

52W Low

$37.02

52W High

$78.48

Market Cap

$5.02B

Volume

1.27M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

38.5%

Avg Negative

25.5%

Avg Neutral

36.0%

News Feed

Could CRISPR Therapeutics Stock Help You Retire a Millionaire?

The Motley Fool·8/31/2021·↓ negative

Crispr Therapeutics: Lucrative Partnerships And Promising Data Increase Its Appeal

Seeking Alpha·8/28/2021·↑ positive

Earnings Growth & Price Strength Make CRISPR Therapeutics AG (CRSP) a Stock to Watch

Zacks Investment Research·8/24/2021·↑ positive

What's Next For CRISPR Stock After An 11% Fall In A Week?

Forbes·8/20/2021·↓ negative

Updated Clinical and Financial Data Make the Case for CRISPR Therapeutics

InvestorPlace·8/19/2021·↑ positive

Why CRISPR Therapeutics Stock Fell 25.2% in July

The Motley Fool·8/6/2021·↓ negative

CRSP Stock: The Good News Goosing CRISPR Therapeutics Shares Today

InvestorPlace·7/30/2021·↑ positive

CRISPR Therapeutics (CRSP) Q2 Earnings Beat, Revenues Up Y/Y

Zacks Investment Research·7/30/2021·↑ positive

CRISPR Therapeutics AG (CRSP) Tops Q2 Earnings and Revenue Estimates

Zacks Investment Research·7/29/2021·↑ positive

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results

GlobeNewsWire·7/29/2021·↑ positive